Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
Yüksel Ürün
Apr 27, 2024, 09:36 |
Blog
Yüksel Ürün: The next step if a PSMA PET scan shows a positive bone lesion without a CT correlate in high-risk prostate cancer
Yüksel Ürün, Professor at the Faculty of Medicine, Ankara University, Turkey, shared on X/Twitter: "What…
Apr 26, 2024, 08:52 |
Blog
Yuksel Urun: A brilliant perspective and a lesson-laden approach from Bernard Escudier, Gustave Roussy
Yuksel Urun, Professor in Department of Medical Oncology at Ankara University School of Medicine, shared…
Apr 26, 2024, 08:22 |
Blog
Yuksel Urun: Europe emphasized program implementation for patient and organization support
Yuksel Urun, Professor in Department of Medical Oncology at Ankara University School of Medicine, shared…
Apr 23, 2024, 23:49 |
Drugs
Yüksel Ürün: Updated 1st-line treatment in mRCC!
Yüksel Ürün, Doctorate Professor at the Faculty of Medicine, Ankara University, Turkey, shared a post…
Apr 14, 2024, 10:45 |
Drugs
Final pre-spectified overall survival analysis of CLEAR, a phase III study - summarized by Yuksel Urun
Yuksel Urun, Professor in Department of Medical Oncology at Ankara University School of Medicine, shared…
Apr 7, 2024, 11:45 |
Drugs
Yüksel Ürün: Adding immunotherapy to cabozantinib for mccRCC after 1st line immunotherapy showed no extra benefit in real-world data
Yüksel Ürün, Doctorate Professor at the Faculty of Medicine, Ankara University, Turkey, shared a post…
Apr 2, 2024, 21:45 |
Insight
Yüksel Ürün: KEYNOTE-412 trial shows pembrolizumab + chemoradiotherapy doesn't significantly improve event-free survival in unselected advanced head and neck squamous cell carcinoma vs placebo
Apr 1, 2024, 13:09 |
Insight
Yüksel Ürün: This research suggests ctDNA could revolutionize pre-surgical decision-making and treatment strategies, ensuring more personalized care
Yüksel Ürün, Medical Oncologist at Ankara University, shared a post on X/Twitter: "Circulating tumor DNA…
Mar 28, 2024, 03:11 |
Drugs
Yüksel Ürün: US FDA approves mirvetuximab soravtansine-gynx for FRα+ platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer
Yüksel Ürün, Professor of Medical Oncology at Ankara University School of Medicine, shared a post…
Mar 20, 2024, 22:40 |
Blog
Yüksel Ürün: Encouraging trend in survival for metastatic prostate cancer!
Yüksel Ürün, Professor of medicine in the Department of Medical Oncology of Ankara University School of…
4
5
6
7
8
All:
113
Posts:
51 - 60
A Manifesto to Improve Cancer Care in Conflict-Affected Areas: The Lancet
Why does Lionel Messi donate so much to charity?
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
Facebook
RSS Feed
Twitter
Linkedin
Youtube